We are live on ! Find out more
HCM

Howard Capital Management Portfolio holdings

AUM $8.4B
1-Year Est. Return 51.89%
This Fund
S&P 500
This Quarter Est. Return
+14.11%
1 Year Est. Return
+51.89%
3 Year Est. Return
+129.27%
5 Year Est. Return
+125.54%
10 Year Est. Return
AUM
$437M
AUM Growth
+$81.8M
Cap. Flow
+$46.3M
Cap. Flow %
10.6%
Top 10 Hldgs %
91.72%
Holding
54
New
4
Increased
43
Reduced
4
Closed
2

Sector Composition

Rank Sector Weight
1 Miscellaneous 96.4%
2 Technology 1.24%
3 Communication Services 0.62%
4 Healthcare 0.53%
5 Consumer Discretionary 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
51
Regeneron Pharmaceuticals
REGN
$79.7B
$205K 0.05%
366
+27
+8% +$16.4K
AAL icon
52
American Airlines Group
AAL
$8.45B
$131K 0.03%
10,683
-3,859
-27% -$48.4K
BMY icon
53
Bristol-Myers Squibb
BMY
$130B
-8,671
Closed -$522K
VTI icon
54
Vanguard Morningstar Total Stock Market ETF
VTI
$681B
-1,544
Closed -$245K

Similar funds

Howard Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Howard Capital Management held 54 positions worth $437M, up 23% from $355M the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Howard Capital Management deployed $46.3M of net new capital in Q3 2020, opening 4 new positions and adding to 43 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 7,561 shares worth $1.23M.

By sector, the portfolio is most concentrated in Miscellaneous at 96% of assets, up from 96% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $210K trimmed.

  • Howard Capital Management's largest Q3 2020 buy was iShares 20+ Year Treasury Bond ETF: 7,561 shares worth $1.23M.
  • Howard Capital Management added most to iShares US Consumer Discretionary ETF in Q3 2020, an estimated $22.1M increase.
  • Howard Capital Management's biggest Q3 2020 reduction was Vertex Pharmaceuticals, cutting an estimated $210K.
  • Howard Capital Management fully exited Bristol-Myers Squibb in Q3 2020, selling an estimated $522K.
  • Howard Capital Management's ten largest holdings make up 92% of its $437M portfolio in Q3 2020.
  • Howard Capital Management opened 4 new positions and closed 2 in Q3 2020.
  • Howard Capital Management's portfolio value rose 23% quarter-over-quarter to $437M.

Based on Howard Capital Management's 13F filing for Q3 2020, filed 7 Oct 2020.